The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride

Documenti analoghi

• A Prospective Study of Reducing Unnecessary Prostate Biopsy in Patients with High Serum Prostate-Specific Antigen with Consideration of Prostatic Inflammation
  di: Lee, An Gu, et al.
  Pubblicazione: (2012)
• Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
  di: Kuiper, Josephina G., et al.
  Pubblicazione: (2016)
• The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
  di: Kim, Hyung-Sang, et al.
  Pubblicazione: (2012)
• Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
  di: Park, Sung Woon, et al.
  Pubblicazione: (2010)
• The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels.
  di: Cote, R. J., et al.
  Pubblicazione: (1998)